Full name
NEUROCLINIC SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
uses securityreCAPTCHA
86.22.Z - Specialist medical practice activities
72.19.Z - Other research and experimental development on natural sciences and engineering
85.60.Z - Educational support activities
86.21.Z - General medical practice activities
86.90.A - Physiotherapeutical activities
86.90.D - Paramedical activities
86.90.E - Other human health activities notelsewhere classified
2020 | 2021 | 2022 | ||
---|---|---|---|---|
K PLN | K PLN | K PLN | % | |
Profit (loss) on sale | ||||
Gross profit (loss) | 8,3 | 3,3 | 8,5 | 155,9 |
EBITDA | 10,4 | 7,4 | 12,6 | 70,1 |
Short time liabilities | 15,9 | 21,8 | 40,6 | 86,3 |
Other operating costs | ||||
Equity capital | 56,2 | 59,5 | 67,3 | 13 |
Operating profit (EBIT) | 8,3 | 3,3 | 8,5 | 156,6 |
Assets | 76,7 | 81,3 | 107,9 | 32,7 |
Net profit (loss) | 8,3 | 3,3 | 7,8 | 134,8 |
Cash | 17,7 | 17,8 | 48 | 169 |
Net income from sale | 334,4 | 541,5 | 570,1 | 5,3 |
Liabilities and provisions for liabilities | 20,5 | 21,8 | 40,6 | 86,3 |
Working assets | 26,1 | 34,8 | 65,5 | 88,1 |
Other income costs | ||||
Depreciation | 2 | 4,1 | 4,1 | 0 |
% | % | % | p.p. | |
Profitability of capital | 14,8 | 5,6 | 11,5 | 5,9 |
Equity capital to total assets | 73,3 | 73,2 | 62,3 | -10,9 |
Gross profit margin | 2,5 | 0,6 | 1,5 | 0,9 |
EBITDA Margin | 3,1 | 1,4 | 2,2 | 0,8 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 17 | 15 | 26 | 11 |
Current financial liquidity indicator | ||||
Net dept to EBITDA |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane